|
| |
|
Sify.com » Topics » US FDA
US FDA News
Aurobindo posts Rs 28.54 cr net loss Hyderabad-based generic formulations and bulk drugs manufacturer Aurobindo Pharma Limited reported a consolidated net loss of Rs 28.54 crore for the quarter ended December 31, 2011, as it had to incur a foreign exchange loss of Rs 144.5 crore. The company had reported a net profit of Rs 188.83 crore in the corresponding quarter last year. Net sales grew 7.74 per cent in the quarter under review to
Hikal`s API manufacturing plant to be ready by June'12
Hikal Ltd, the outsourcing partner for pharmaceuticals, biotech, agrochemicals and speciality chemicals industries announced that the company's multipurpose facility to manufacture active
Lowest price point for medical devices irks industry
Medical equipment makers have complained against the recent decisions of the Central Government Health Scheme (CGHS) and Employees’ State Insurance Corporation (ESIC) to notify three
USFDA approval to enhance revenues, profits
Dr Reddy’s Laboratories’ scrip jumped three per cent after the company announced it had received the US Food and Drug Administration (FDA) go-ahead to market Fondaparinux Sodium
High returns from smaller doses
Presence in fast growing segments and markets should enable pharma companies like IPCA, Torrent and Cadila to outperform broader markets.
Suven Life completes long- term studies of its drug
Hyderabad-based Suven Life Sciences Limited (Suven) said that its clinical drug candidate SUVN-502, being developed for central nervous system (CNS) disorders, had completed all the long-term US FDA Galleries
|
|
|
© Copyright Sify Technologies Ltd, 1998-2011. All rights reserved. India News Portal, Sify.com hosted at SifyHosting India's first Level 3 Internet Data Centre. Site optimized for Internet Explorer 5.5 and above. See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise | |
